Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Recombinant Protein / Other Proteins

Recombinant Human SH2B3 Protein, N-His

Catalog #:   YHJ83701 Specific References (50) DATASHEET
Applications: ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Expression system: E. coli
Accession: Q9UQQ2
Protein length: Thr335-Ser561
Overview

Catalog No.

YHJ83701

Expression system

E. coli

Species

Homo sapiens (Human)

Protein length

Thr335-Ser561

Predicted molecular weight

27.35 kDa

Nature

Recombinant

Endotoxin level

Please contact with the lab for this information.

Purity

>90% as determined by SDS-PAGE.

Accession

Q9UQQ2

Applications

ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress

Form

Lyophilized

Storage buffer

Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol.

Reconstitution

Reconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details.

Shipping

In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

Alternative Names

Lymphocyte-specific adapter protein Lnk, SH2B3, Signal transduction protein Lnk, LNK, Lymphocyte adapter protein, SH2B adapter protein 3

Data Image
  • SDS-PAGE
    SDS PAGE for recombinant Human SH2B3 protein
References

Mapping Inherited Genetic Variation with Opposite Effects on Autoimmune Disease and Four Cancer Types Identifies Candidate Drug Targets Associated with the Anti-Tumor Immune Response., PMID:40428397

The Ubiquitination and Degradation of SH2B3 Mediated by MEF2A/WWP2 Axis Restores Microglial Homeostasis to Alleviate Cerebral Microvascular Endothelial Cell Injury in Ischemic Stroke., PMID:40407948

Reduced Function of the Adaptor SH2B3 Promotes T1D via Altered Cytokine-Regulated, T-Cell-Intrinsic Immune Tolerance., PMID:40048557

Dissecting the genetic basis and mechanisms underlying the associations between multiple extrahepatic factors and autoimmune liver diseases., PMID:39741931

Six genetic variants are associated with cardiovascular disease independently from canonical risk factors: a new method to refine GWAS results based on the UKBiobank phenotype database., PMID:39704901

Donor selection for allogeneic hematopoietic cell transplant in a patient with JAK2 V617F primary myelofibrosis and SH2B3/LNK germline variant., PMID:39672944

FABIO: TWAS fine-mapping to prioritize causal genes for binary traits., PMID:39621803

[Childhood acute lymphoblastic leukemia with CREBBP gene mutation: a clinical analysis of 14 cases]., PMID:39587751

LNK/SH2B3 Loss Exacerbates the Development of Myeloproliferative Neoplasms in CBL-deficient Mice., PMID:39560864

Fine-mapping and molecular characterisation of primary sclerosing cholangitis genetic risk loci., PMID:39505854

Clinical and genetic profile of Chinese patients with indolent natural killer-cell lymphoproliferative disorder of the gastrointestinal tract., PMID:39276532

[Genetic Variation of SH2B3 in Patients with Myeloid Neoplasms]., PMID:39192417

Proteome- and Transcriptome-Wide Genetic Analysis Identifies Biological Pathways and Candidate Drug Targets for Preeclampsia., PMID:39119725

Novel genetic association between obesity, colorectal cancer, and inflammatory bowel disease., PMID:38932827

Null-type SH2B3 mutations are potential drivers in a subset of Ph-negative myeloproliferative neoplasms., PMID:38924136

Negative regulation of SH2B3 by SMYD5 controls epithelial-mesenchymal transition in lung cancer., PMID:38723947

Clinical laboratory characteristics and gene mutation spectrum of Ph-negative MPN patients with atypical variants of JAK2, MPL, or CALR., PMID:38618943

SH2B3 alterations in a novel genetic condition, juvenile myelomonocytic leukemia, and myeloproliferative neoplasia., PMID:38618667

Diagnostic Approaches to Investigate JAK2-Unmutated Erythrocytosis Based on a Single Tertiary Center Experience., PMID:38568469

The role of longevity-related genetic variant interactions as predictors of survival after 85 years of age., PMID:38484896

A multi-ancestry genome-wide association study in type 1 diabetes., PMID:38453145

Rare SH2B3 coding variants in lupus patients impair B cell tolerance and predispose to autoimmunity., PMID:38417019

Tyrosine kinase inhibitor resistance in de novo BCR::ABL1-positive BCP-ALL beyond kinase domain mutations., PMID:38386975

LNK/SH2B3 loss of function increases susceptibility to murine and human atrial fibrillation., PMID:38377486

Genotypes predisposing for celiac disease and autoimmune diabetes and risk of infections in early childhood., PMID:38374560

Protein-protein interaction network-based integration of GWAS and functional data for blood pressure regulation analysis., PMID:38326862

Mendelian randomization study highlights hypothyroidism as a causal determinant of alopecia areata., PMID:38292771

Mapping inherited genetic variation with opposite effects on autoimmune disease and cancer identifies candidate drug targets associated with the anti-tumor immune response., PMID:38234717

LNK/SH2B3 as a novel driver in juvenile myelomonocytic leukemia., PMID:38152053

DNA Copy Number Alterations and Copy Neutral Loss of Heterozygosity in Adult Ph-Negative Acute B-Lymphoblastic Leukemia: Focus on the Genes Involved., PMID:38139431

STAT5a and SH2B3 novel mutations display malignancy roles in a triple-negative primary myelofibrosis patient., PMID:38135698

Hematopoietic and eosinophil-specific LNK(SH2B3) deficiency promotes eosinophilia and arterial thrombosis., PMID:38096361

Germline heterozygous SH2B3-mutations and (idiopathic) erythrocytosis: Detection of a previously undescribed mutation., PMID:38024597

Germline bi-allelic SH2B3/LNK alteration predisposes to a neonatal juvenile myelomonocytic leukemia-like disorder., PMID:37981895

Polycystic Ovary Syndrome Physiologic Pathways Implicated Through Clustering of Genetic Loci., PMID:37967238

Genomic Mutation Profiles of Patients with Acute Myeloid Leukemia in Korea: a Single-Center Experience., PMID:37948498

Genomic alterations in blast phase of BCR::ABL1-negative myeloproliferative neoplasms., PMID:37867386

Systemic aspergillosis in a patient with interferon gamma receptor 1 deficiency; a case report., PMID:37277724

Integration of Mendelian randomisation and systems biology models to identify novel blood-based biomarkers for stroke., PMID:36958462

Acquired uniparental isodisomies involving chromosome 12 in paediatric B-cell precursor acute lymphoblastic leukaemia: Associations with chromosome 21 gains and SH2B3 mutations., PMID:36899493

Genetic correlates of vitamin D-binding protein and 25-hydroxyvitamin D in neonatal dried blood spots., PMID:36792583

Molecular analysis of phenotypic heterogeneity in JAK2V617F-positive myeloproliferative neoplasms reveals a potential target for therapy., PMID:36708268

Replication of association at the LPP and UBASH3A loci in a UK autoimmune Addison's disease cohort., PMID:36651163

Src homology 2-B adapter protein 3 C784 T and Methylenetetrahydrofolate reductase C677 T Polymorphisms and Inflammation Markers in ST-segment Elevation Myocardial Infarction Patients., PMID:36650025

CTLA4, SH2B3, and CLEC16A diversely affect the progression of early islet autoimmunity in relatives of Type 1 diabetes patients., PMID:36622793

Exploring potential shared genetic influences between rheumatoid arthritis and blood lipid levels., PMID:36455308

Coronary artery disease risk factors affected by RNA modification-related genetic variants., PMID:36204584

A Single Nucleotide Polymorphism in SH2B3/LNK Promotes Hypertension Development and Renal Damage., PMID:36169218

Predictors of the Initiation of Islet Autoimmunity and Progression to Multiple Autoantibodies and Clinical Diabetes: The TEDDY Study., PMID:36150053

Immune dysregulation associated with co-occurring germline CBL and SH2B3 variants., PMID:36123612

Datasheet
$ 313
Product specifications
100 μg 313 1 mg 1629

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Recombinant Human SH2B3 Protein, N-His [YHJ83701]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only